Sign up for the QMED & MD+DI Daily newsletter.
Fitbit’s Role in the Fight to Understand COVID-19
Fitbit is leading the charge in the effort to gain a better understanding of COVID-19. On this episode of Let’s Talk Medtech we spoke with Dr. Conor Heneghan Lead Research Scientist at Fitbit about a recent study the company conducted regarding the virus.
Omar Ford
January 8, 2021
1 Min Read
Sundry Photography-stock.adobe.com
Late last year, Nature Partner Journal, npj Digital Medicine published findings from Fitbit’s COVID-19 study, which aims to determine whether the wearable can help build an algorithm to detect COVID-19 before symptoms start.
The published results show that breathing rate, resting heart rate and heart rate variability (HRV) are all useful metrics for indicating the onset of illness, making wearables a key tool in the fight against COVID-19, as it’s clear that patients' bodies may signal impact from the disease before more noticeable symptoms appear.
On this episode of Let’s Talk Medtech, MD+DI’s managing editor Omar Ford spoke with Dr. Conor Heneghan Lead Research Scientist at Fitbit about the study. Click here for the episode.
About the Author
You May Also Like
.png?width=700&auto=webp&quality=80&disable=upscale)
.png?width=700&auto=webp&quality=80&disable=upscale)
.png?width=700&auto=webp&quality=80&disable=upscale)